Sunitinib Malate Capsule, featured in Loncom Pharma's Anti-cancer Drugs, is instrumental in cancer treatment. It inhibits cancer-related pathways, providing new possibilities for cancer patients and enhancing their well-being.
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.
